Evaluation of Hyivy Floora in Managing Interstitial Cystitis/Bladder Pain Syndrome/High-tone Pelvic Floor Dysfunction
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07038512
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- High Tone Pelvic Floor Dysfunction
- Interstitial Cystitis, Chronic
- Interstitial Cystitis/Painful Bladder Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Floora Pelvic Rehabilitation Vaginal Dilator — DEVICEThe Floora Pelvic Rehabilitation Vaginal Dilator, created by Hyivy Health Inc, is a multi-therapy hand held ergonomic intravaginal wand device that is designed to be used in the comfort of the user's home. The Floora has two main therapeutic functions, controllable dilation and thermal therapy. It is the first vaginal dilator that performs auto-dilation using one or two air chambers inflated from the device surface by an internal pump, eliminating the need for reinsertion. The device is equipped with biosensors that measure the pressure from the vaginal canal which allows this device to provide a gradual and gentle stretch to the pelvic floor muscles. The thermal therapy is achieved through an electrical circuit, changing the temperature of the device in small increments. Users are able to force-stop and change the temperature and dilation settings during a session.
Study Details
The purpose of this study is to test the safety and effectiveness of the Floora Pelvic Rehabilitation Vaginal Dilator in females with Interstitial Cystitis/ Bladder pain Syndrome (IC/BPS) and High-tome Pelvic Floor Dysfunction (HTPFD). After enrollment, participants will be given a Floora device and will be instructed to use the device at least three times per week for 12-weeks in the comfort of their home. Each session consists of 10 minutes of heat and 10 minutes of dilation. All participants will be required to attend 3 in-person clinic visits and there will be two follow-up phone-calls throughout the 16-week trial period.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Apr 2026
- Primary completion
- Oct 31, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionParticipants will be instructed to use the Hyivy Floora Pelvic Rehabilitation Vaginal Dilator at least three times per week for a total of 12-weeks. Each session consists of 10 minutes of heat and 10 minutes of dilation.
Primary Outcome Measure
Pelvic Pain Score [ Time Frame: Baseline ]
Central Contacts
- Kaylee Ferrara, MA336-713-1693
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Atrium Health Wake Forest Baptist Urology | Winston-Salem | North Carolina | 27103 | Amr El Haraki, MD (SUB_INVESTIGATOR) |
Find similar trials in Winston-Salem, NC
Related Studies
- Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentRecruiting · Vanderbilt University Medical Center · Franklin, Tennessee
- Comparing Adjuvant Treatments for High Tone Pelvic Floor DysfunctionPHASE2/PHASE3 · Recruiting · University of Michigan · Ann Arbor, Michigan